Is Shilajit Safe for Men? What the Research on Prostate and Cancer Safety Actually Shows

Why does the prostate question come up for men researching shilajit?

A man who starts researching shilajit for bone density, energy, or a low testosterone number usually runs into the same wall within the first few minutes. Something in the back of his mind flags testosterone and prostate cancer as connected, and he wants that question answered before he goes any further.

That instinct did not come from nowhere. Testosterone replacement therapy has carried a prostate warning on its label for years, rooted in research from the 1940s that treated testosterone as cancer fuel. More recent research has revised that old picture considerably, but the caution itself is reasonable, not paranoid, and it deserves a direct answer with the actual studies attached rather than a reassurance with nothing behind it.

The distinction that matters before anything else

Testosterone replacement therapy and shilajit do not work the same way. That difference is the entire reason the research below was even worth running.

• TRT adds testosterone to the body from an outside source
• TRT typically shuts down the body's own testosterone production
• Shilajit does not add testosterone from outside the body
• Shilajit is not a hormone by any laboratory definition
• The prostate research below specifically tested whether it behaves like one anyway

Does shilajit flood the body with testosterone the way TRT does?

Pandit and colleagues (2016) ran a 90 day study in men and found the actual mechanism looks nothing like TRT. Shilajit raised free testosterone, the portion of testosterone the body can actually use, to about 120 percent of where it started, an increase of roughly 19 percent.

The part that matters most for the prostate question sits in what did not happen. LH and FSH, the pituitary signals that drive the body's own testosterone production, stayed steady throughout the study. That is the signature of a body still running its own system, not one being flooded and shut down from outside.

TRT versus shilajit's fulvic acid, side by side

That mechanism difference is exactly why researchers went looking for direct laboratory evidence on the cancer question instead of assuming the answer either way.

Has shilajit been tested against prostate cancer cells specifically?

Yes, and the results ran opposite to what feeding a cancer would look like. A 2026 systematic review published in Cureus, covering laboratory research across many cancer cell lines, found that shilajit triggered apoptosis, programmed cell death, through ROS generation and inhibition of the NF-kB and IKK pathways, cancer cells that cannot easily evade dying, while relatively sparing normal cells in the same experiments.

Three separate findings sit underneath that review. Each one is worth naming honestly, not blended together.

• A 2016 study found fulvic acid caused immune cells to release compounds that killed LNCaP, a widely used androgen sensitive prostate cancer cell line, along with liver and leukemia cell lines in the same experiment
• That same 2016 study did not test a normal, non-cancerous prostate cell line for comparison, so it cannot support a claim that healthy prostate tissue was specifically spared
• A 2021 study found shilajit was cytotoxic to bladder cancer cells, urinary tract adjacent tissue, while normal bladder cells in the same experiment were far more tolerant of it
• The bladder finding is the clearest laboratory example of the pattern, killing abnormal cells while relatively sparing healthy ones
• All of this is in vitro, meaning cells in a laboratory dish, not a living human body

Reading the prostate evidence at the size it actually is

The LNCaP finding is genuinely encouraging and genuinely incomplete on its own. It shows fulvic acid's downstream effects reached a prostate specific cancer cell line and killed it, which answers the fear that anything testosterone adjacent must feed prostate cancer. It does not, on its own, prove that healthy prostate tissue is spared, because that specific comparison was not run in that specific paper. The bladder study fills part of that gap for adjacent tissue, and the broader systematic review supports the general pattern across many cancer types, but a dedicated human prostate trial does not exist yet.

What does the broader cancer safety research show?

Separate from the prostate specific findings, shilajit's general safety record is worth knowing on its own terms. Across every human clinical study conducted on shilajit, zero serious adverse events have been reported. A 90 day rat toxicology study of a comparable fulvic and humic acid preparation found no organ toxicity and no genotoxicity, even at doses well above typical human intake.

The same pattern shows up elsewhere too. Not a hormone, and it spares healthy cells while it works.

That pattern strengthens the overall picture rather than resting on one study alone.

• A 2020 in vitro study found shilajit reduced viability in MCF-7 and MDA-MB-231 breast cancer cell lines while leaving normal MCF-10A breast cells substantially less affected
• A 2024 mouse study using fulvic acid suppressed tumor growth in a breast cancer xenograft model in every treatment group compared to untreated controls
• Multiple independently conducted studies, working with different cancer types and different research methods, converged on the same direction of effect
• None of these findings, prostate, bladder, or breast, constitute a human treatment or prevention claim
• The convergence across cancer types is a better early signal than any single study on its own

Sourcing still matters for the safety picture

Resin quality varies enormously across the shilajit market, and a safety record only applies to the purified form that was actually studied. Optimum shilajit comes from the Altai mountains, cold pressed and purified, with every batch tested by an independent lab for heavy metals and published for Prop 65 compliance in California. It is family owned, out of Florida, and ships as a box of tablets, not a loose powder that loses potency before it reaches you.

Pure Altai shilajit, tested in full

Sourced from the Altai mountains, purified, and lab tested for heavy metals on every batch, with the report published for anyone to read. If you want the product built around this research, here is .

See Optimum Shilajit